Windtree

Highlights: Windtree has secured $520M for its BNB Treasury strategy. A total commitment of $700M targets a large-scale BNB acquisition. Shareholder approval is required to activate the $500M ELOC. Biotechnology company Windtree Therapeutics has announced two financial arrangements to raise […]

Highlights: Windtree has launched a $200M BNB treasury backed by institutional investors. The firm will gain direct BNB exposure, a first for Nasdaq-listed companies. The firm aims to hold BNB directly and through Osprey BNB Chain Trust. Windtree Therapeutics, a […]